This is the point where most clinicians evaluate whether to continue, switch approaches, or cycle off
How Axis Peptide Labs measures up Measured against those criteria, here is what Axis Peptide Labs offers, all verifiable rather than asserted: The table is not a claim about anyone else
10.1016/j.jhep.2018.10.037 114 ZhangC.YangM
They cannot legally compound non-approved peptides
Black DM, et al
Heres what the clinical data shows: Most Common: Nausea (affecting 15-44% of users), diarrhea (10-30%), vomiting (7-25%), and constipation (6-24%) Severity: 98.1% of gastrointestinal side effects are mild or moderate, with 99.5% being non-serious Duration: Median duration is 8 days for nausea, 3 days for diarrhea, and 2 days for vomiting Timing: Most side effects occur during initial weeks and dose escalation, declining over time Discontinuation: Only 4.3-10% of users discontinue therapy due to side effects Serious Events: Rare, with no increased risk of pancreatitis or malignancy in clinical trials Management: Slow dose titration, dietary modifications, and hydration significantly reduce symptoms Important Note: Weight loss is NOT caused by side effects